CUC Inc. invested in Nhi Dong 315 – a major operator of pediatric, obstetrics and gynecology clinics in Ho Chi Minh City, Vietnam.
CUC Inc. (Chuo-ku, Tokyo, CEO: Keita HAMAGUCHI, hereinafter referred to as “CUC”) announced that CUC invested in Nhi Dong 315 Group (Ho Chi Minh City, Vietnam, CEO: Nguyen Huynh Van Vy, hereinafter referred to as “Nhi Dong 315”), which operates pediatric, obstetrics and gynecology clinics in Ho Chi Minh City, Vietnam, on 20th September 2022.
Purpose of the Investment
Nhi Dong 315 started its business in 2019 and has grown into the leading pediatric clinics operator in HoChi Minh City. It currently operates 46 pediatric, obstetrics and gynecology clinics, which provide high-quality healthcare services to growing middle income people in Vietnam. CUC decided to invest in Nhi Dong 315 to accelerate Nhi Dong 315’s growth through business collaboration. Nhi Dong 315 and CUC will work together to provide better healthcare services to more people in Vietnam.
Future Prospects
Leveraging CUC’s expertise to support pediatric clinics in Japan, CUC plans to support Nhi Dong 315’s growth through staff exchange, educational support and co-marketing effort. CUC will provide supports to more partners in Vietnam and strive to achieve the mission to create hope through healthcare.
Prospects of the Vietnamese healthcare market
The Vietnamese healthcare market is expected to grow at the rate of 11% CAGR over 2017-2027*1. Healthcare spending per capita in 2019 increased to 181USD*2, which is about 10x of 2000. Broader access to high quality healthcare service is sought in Vietnam, particularly in urban areas.
*Reference
(*1) Fitch Solutions, Inc. Healthcare Reforms In Vietnam Present Upside Potential But Risks Remain (October, 2018) https://www.fitchsolutions.com/pharma-healthcare/healthcare-reforms-vietnam-present-upside-potential-risks-remain-22-10-2018
(*2) THE WORLD BANK. Current health expenditure per capita (current US$) – Vietnam https://data.worldbank.org/indicator/SH.XPD.CHEX.PC.CD?locations=VN